Influence of dispersive agent on nanomaterial agglomeration and implications for biological effects in vivo or in vitro

Toxicology in Vitro

Volumn 29, Issue 1, 2015, Pages 182-186

  Sauer, Ursula G ^a   Aumann, Alexandra ^b   Ma Hock, Lan ^b   Landsiedel, Robert ^b   Wohlleben, Wendel ^b  

^a Scientific Consultancy Animal Welfare   (Germany)

^b BASF SE   (Germany)

Author keywords

Agglomeration; Bovine serum albumin; Curosurf ; Dispersing agents; In vitro particokinetics; Nanomaterial

Indexed keywords

BOVINE SERUM ALBUMIN; MULTI WALLED NANOTUBE; NANOMATERIAL; PORACTANT; CARBON NANOTUBE; SURFACTANT ASSOCIATED PROTEIN;

AGGLOMERATION; ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CULTURE MEDIUM; DISPERSION; HYDRODYNAMICS; IN VITRO STUDY; MATERIALS TESTING; PHYSICAL PHENOMENA; ANIMAL; BOVINE; DOSE RESPONSE; METABOLISM; PARTICLE SIZE; PIG; ULTRACENTRIFUGATION;

ANIMALS; CATTLE; DOSE-RESPONSE RELATIONSHIP, DRUG; IN VITRO TECHNIQUES; NANOSTRUCTURES; NANOTUBES, CARBON; PARTICLE SIZE; PULMONARY SURFACTANT-ASSOCIATED PROTEINS; SERUM ALBUMIN, BOVINE; SWINE; ULTRACENTRIFUGATION;

EID: 84909606495     PISSN: 08872333     EISSN: 18793177     Source Type: Journal    
DOI: 10.1016/j.tiv.2014.10.011     Document Type: Article

References (30)

1. Bihari P., Vippola M., Schultes S., Praetner M., Khandoga A.G., Reichel C.A., Coester C., Tuomi T., Rehberg M., Krombach F. Optimized dispersion of nanoparticles for biological in vitro and in vivo studies. Part. Fibre Toxicol. 2008, 5:14.
2. Cohen J.M., Teeguarden J.G., Demokritou P. An integrated approach for the in vitro dosimetry of engineered nanomaterials. Part. Fibre Toxicol. 2014, 11:20.
3. DeLoid G., Cohen J.M., Darrah T., Pyrgiotakis G., Wohlleben W., Demokritou P. Estimating effective density of engineered nanomaterials for accurate in vitro dosimetry. Nat. Commun. 2014, 5:3514.
4. Gasser M., Wick P., Clift M.J., Blank F., Diener L., Yan B., Gehr P., Krug H.F., Rothen-Rutishauser B. Pulmonary surfactant coating of multi-walled carbon nanotubes (MWCNTs) influences their oxidative and pro-inflammatory potential in vitro. Part. Fibre Toxicol. 2012, 9(1):17.
5. Hinderliter P.M., Minard K.R., Orr G., Chrisler W.B., Thrall B.D., Pounds J.G., Teeguarden J.G. ISDD: a computational model of particle sedimentation, diffusion and target cell dosimetry for in vitro toxicity studies. Part. Fibre Toxicol. 2010, 7(1):36.
6. Landsiedel R., Ma-Hock L., Haussmann H.J., van Ravenzwaay B., Kayser M., Wiench K. Inhalation studies for the safety assessment of nanomaterials: status quo and the way forward. Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol. 2012, 4(4):399-413.
7. Landsiedel, R., Sauer, U.G., Ma-Hock, L., Schnekenburger, J., Wiemann, M., 2014. Pulmonary toxicity of nanomaterials: a critical comparison of published in vitro assays and in vivo inhalation or instillation studies. Nanomedicine (in press).
8. Lundqvist M., Stigler J., Cedervall T., Berggård T., Flanagan M.B., Lynch I., Elia G., Dawson K.A. The evolution of the protein corona around nanoparticles: a test study. ACS Nano 2011, 5(9):7503-7509.
9. Maynard A.D. Experimental determination of ultrafine TiO2 deagglomeration in a surrogate pulmonary surfactant: preliminary results. Ann. Occup. Hyg. 2002, 46:197-202.
10. Monopoli M.P., Walczyk D., Campbell A., Elia G., Lynch I., Bombelli F.B., Dawson K.A. Physical-chemical aspects of protein corona: relevance to in vitro and in vivo biological impacts of nanoparticles. J. Am. Chem. Soc. 2011, 133(8):2525-2534.
11. Monopoli M.P., Åberg C., Salvati A., Dawson K.A. Biomolecular coronas provide the biological identity of nanosized materials. Nat. Nanotechnol. 2012, 7:779-786.
12. Nepal D., Geckeler K.E. Proteins and carbon nanotubes: close encounter in water. Small 2007, 3(7):1259-1265.
13. OECD, 2010. Guidance manual for the testing of manufactured nanomaterials: OECD's sponsorship programme. First revision. ENV-JM-MONO (2009) 20-REV, OECD, Paris, 2 June 2010.
14. Oomen A.G., Bos P.M.J., Fernandes T.F., Hund-Rinke K., Boraschi D., Byrne H.J., Aschberger K., Gottardo S., van der Kammer F., Kühnel D., Hristozov D., Marcomini A., Migliore L., Scott-Fordsmand J., Wick P., Landsiedel R. Concern-driven integrated approaches to nanomaterial testing and assessment - report of the nanosafety cluster working group 10. Nanotoxicology 2014, 8:334-348.
15. Planken K.L., Coelfen H. Analytical ultracentrifugation of colloids. Nanoscale 2010, 2(10):1849-1869.
16. Ruge C.A., Schaefer U.F., Herrmann J., Kirch J., Cañadas O., Echaide M., Pérez-Gil J., Casals C., Müller R., Lehr C.M. The interplay of lung surfactant proteins and lipids assimilates the macrophage clearance of nanoparticles. Public Library Sci. One 2012, 7(7):e40775.
17. Sager T.M., Porter D.W., Robinson V.A., Lindsley W.G., Schwegler-Berry D.E., Castranova V. An improved method to disperse nanoparticles for in vitro and in vivo investigation of toxicity. Nanotoxicology 2007, 1:118-129.
18. Sauer U.G., Vogel S., Aumann A., Strauss V., Dammann M., Treumann S., Wohlleben W., Kolle S.N., Ma-Hock L., Gröters S., Wiench K., van Ravenzwaay B., Landsiedel R. Applicability of rat precision-cut lung slices in evaluating nanomaterial cytotoxicity, apoptosis, oxidative stress, and inflammation. Toxicol. Appl. Pharmacol. 2014, 276:1-20.
19. Schaefer J., Schulze C., Marxer E.E., Schaefer U.F., Wohlleben W., Bakowsky U., Lehr C.M. Atomic force microscopy and analytical ultracentrifugation for probing nanomaterial protein interactions. ACS Nano 2012, 6(6):4603-4614.
20. Schleh C., Kreyling W.G., Lehr C.-M. Pulmonary surfactant is indispensable in order to simulate the in vivo situation. Part. Fibre Toxicol. 2013, 10:6.
21. Schulze C., Schaefer U.F., Ruge C.A., Wohlleben W., Lehr C.M. Interaction of metal oxide nanoparticles with lung surfactant protein A. Eur. J. Pharm. Biopharm. 2011, 77(3):376-383.
22. Soto K.F., Carrasco A., Powell T.G., Garza K.M., Murr L.E. Comparative in vitro cytotoxicity assessment of some manufactured nanoparticulate materials characterized by transmission electron microscopy. J. Nanopart. Res. 2005, 7:145-169.
23. Taurozzi J., Hackley V.C., Wiesner M.R. Ultrasonic dispersion of nanoparticles for environmental, health and safety assessment - issues and recommendations. Nanotoxicology 2011, 5(4):711-729.
24. Teeguarden J.G., Hinderliter P.M., Orr G., Thrall B.D., Pounds J.G. Particokinetics in vitro: dosimetry considerations for in vitro nanoparticle toxicity assessments. Toxicol. Sci. 2007, 95:300-312.
25. Vippola M., Falck G.C., Lindberg H.K., Suhonen S., Vanhala E., Norppa H., Savolainen K., Tossavainen A., Tuomi T. Preparation of nanoparticle dispersions for in-vitro toxicity testing. Hum. Exp. Toxicol. 2009, 28(6-7):377-385.
26. Vranic S., Garcia-Verdugo I., Darnis C., Sallenave J.M., Boggetto N., Marano F., Boland S., Baeza-Squiban A. Internalization of SiO2 nanoparticles by alveolar macrophages and lung epithelial cells and its modulation by the lung surfactant substitute Curosurf. Environ. Sci. Pollut. Res. Int. 2013, 20(5):2761-2770.
27. Wang L., Castranova V., Mishra A., Chen B., Mercer R.R., Schwegler-Berry D., Rojanasakul Y. Dispersion of single-walled carbon nanotubes by a natural lung surfactant for pulmonary in vitro and in vivo toxicity studies. Part. Fibre Toxicol. 2010, 7(1):31.
28. Wang L., Mercer R.R., Rojanasakul Y., Qiu A., Lu Y., Scabilloni J.F., Wu N., Castranova V. Direct fibrogenic effects of dispersed single-walled carbon nanotubes on human lung fibroblasts. J. Toxicol. Env. Health Part A 2010, 73(5-6):410-422.
29. Wohlleben W. Validity range of centrifuges for the regulation of nanomaterials: from classification to as-tested coronas. J. Nanopart. Res. 2012, 14(12):1300.
30. Zhu M., Nie G., Meng H., Xia T., Nel A., Zhao Y. Physicochemical properties determine nanomaterial cellular uptake, transport and fate. Acc. Chem. Res. 2013, 46(3):622-631.